Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Sun Pharmaceutical Industries Limited (d/b/a Sun Pharma) is an Indian multinational pharmaceutical company headquartered in Mumbai. It manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) in more than 100 countries. It is the largest pharmaceutical company in India and the fourth largest specialty generic…
History, Products, Art & Companies
Explore the main themes, entities and connections around Sun Pharma. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
sun pharma company pharmaceutical us acquired pharmaceuticals india products market generic sparc dermatology largest billion industries limited revenue mumbai stake
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Sun Pharma | Area served | Worldwide | 1.00 | infobox |
| Sun Pharma | Founded | 1983; 43 years ago (1983) | 1.00 | infobox |
| Sun Pharma | Founder | Dilip Shanghvi | 1.00 | infobox |
| Sun Pharma | Headquarters | Mumbai, Maharashtra, India | 1.00 | infobox |
| Sun Pharma | Industry | Pharmaceuticals | 1.00 | infobox |
| Sun Pharma | ISIN | INE044A01036 | 1.00 | infobox |
| Sun Pharma | Key people | Dilip Shanghvi (MD) | 1.00 | infobox |
| Sun Pharma | Net income | ₹11,984 crore (US$1.2 billion) (2025) | 1.00 | infobox |
| Sun Pharma | Number of employees | 41,000+ (2023) | 1.00 | infobox |
| Sun Pharma | Operating income | ₹15,271 crore (US$1.6 billion) (2025) | 1.00 | infobox |
| Sun Pharma | Owner | Dilip Shanghvi family (54.48%) | 1.00 | infobox |
| Sun Pharma | Products | Pharmaceutical drugs | 1.00 | infobox |
| Sun Pharma | Products | generic drugs | 1.00 | infobox |
| Sun Pharma | Products | antiviral drugs | 1.00 | infobox |
| Sun Pharma | Products | over-the-counter drugs | 1.00 | infobox |
| Sun Pharma | Products | vaccines | 1.00 | infobox |
| Sun Pharma | Products | diagnostics | 1.00 | infobox |
| Sun Pharma | Products | contact lenses | 1.00 | infobox |
| Sun Pharma | Products | animal health | 1.00 | infobox |
| Sun Pharma | Products | dietary supplements | 1.00 | infobox |
| Sun Pharma | Products | protein supplements | 1.00 | infobox |
| Sun Pharma | Revenue | ₹52,578 crore (US$5.5 billion) (2025) | 1.00 | infobox |
| Sun Pharma | Total assets | ₹92,100 crore (US$9.6 billion) (2025) | 1.00 | infobox |
| Sun Pharma | Total equity | ₹72,485 crore (US$7.5 billion) (2025) | 1.00 | infobox |
| Sun Pharma | Traded as | BSE: 524715 | 1.00 | infobox |
| Sun Pharma | Traded as | NSE: SUNPHARMA | 1.00 | infobox |
| Sun Pharma | Traded as | BSE SENSEX constituent | 1.00 | infobox |
| Sun Pharma | Traded as | NSE NIFTY 50 constituent | 1.00 | infobox |
| Sun Pharma | Type | Public | 1.00 | infobox |
| Sun Pharma | Website | sunpharma.com | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.